Green Light for WAG and ABC Deal - Analyst Blog

By
A A A

The largest retail pharmacy chain in the U.S., Walgreen Co. ( WAG ) and Alliance Boots continue to make steady progress to boost their global presence in the prescription drug purchasing space. The regulatory approval for the companies' equity investment deal in AmerisourceBergen Corporation ( ABC ), a major pharmaceutical service company in North America, is seen as yet more good news for investors after the positive events last week.

Investors and competitors alike have been looking forward to the regulatory clearance of the 10-year old deal between Walgreens and AmerisourceBergen, effective Sep 1, 2013. The approval boosted market sentiments as shares of Walgreens rose 1.58% on the day of the announcement. On the other hand, other players in the market such as CVS Caremark ( CVS ) are likely to scrutinize its branded and generic drug purchasing network and contemplate strategic possibilities.  

AmerisourceBergen will replace Walgreens' current pharmaceutical distributor Cardinal Health ( CAH ) as the existing contract is set to expire in Aug 2013. AmerisourceBergen already supplies specialty drugs to Walgreens.


Following the clearance, the company and Alliance Boots have the right to purchase a minority stake of 7% in AmerisourceBergen in the open market and another 16% equity stake in 2016 and 2017. As per the approval, the equity stake is exercisable up to 25% in aggregate, after accounting for the stock buyback activity of AmerisourceBergen.

Walgreens' long-term deal with AmerisourceBergen is expected to create a kingpin in the prescription drug purchasing space. Walgreens is optimistic about the financial and operational benefits from the AmerisourceBergen deal for fiscal 2014 with margin expansion and bottom-line accretion.

Walgreens continues to gain positive momentum on the back of strategic deals. Currently, the stock carries a Zacks Rank #3 (Hold).



AMERISOURCEBRGN (ABC): Free Stock Analysis Report

CARDINAL HEALTH (CAH): Free Stock Analysis Report

CVS CAREMARK CP (CVS): Free Stock Analysis Report

WALGREEN CO (WAG): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: Investing , Business , Stocks

Referenced Stocks: ABC , CAH , CVS , WAG

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

What to Wear to a Wedding
What to Wear to a Wedding           
4th of July Outfits
4th of July Outfits                 

Stocks

Referenced

100%
100%
93%

Most Active by Volume

62,287,287
  • $17.03 ▼ 1.10%
26,194,993
  • $30.555 ▲ 1.24%
26,150,957
  • $126.44 ▼ 0.13%
25,197,634
  • $40.59 ▼ 6.26%
25,192,083
  • $19.07 ▲ 1.54%
24,563,617
  • $26.78 ▲ 0.45%
24,474,256
  • $5.85 ▲ 1.56%
24,111,132
  • $8.83 ▲ 2.08%
As of 7/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com